Oil of bitter orange: new topical antifungal agent

W Ramadan1, B Mourad, S Ibrahim

  • 1Department of Dermatology and Venereology, Faculty of Medicine, Tanta University, Egypt.

Abstract

Insights

Oil of bitter orange (OBO) shows promise as a topical antifungal treatment for resistant superficial dermatophyte infections. Different OBO concentrations were tested, with positive results and minimal side effects observed.

Area of Science:

  • Dermatology
  • Mycology
  • Natural Products

Background:

  • Superficial dermatophyte infections are common and can be resistant to conventional therapies.
  • Existing treatments for fungal skin infections sometimes face challenges with efficacy and resistance.

Purpose of the Study:

  • To evaluate the efficacy of oil of bitter orange (OBO) as a topical antifungal agent.
  • To compare different concentrations and application frequencies of OBO for treating dermatophyte infections.

Main Methods:

  • Sixty patients with superficial dermatophyte infections were divided into three groups.
  • Group 1 received 25% OBO emulsion TID; Group 2 received 20% OBO in alcohol TID; Group 3 received pure OBO QD.
  • Clinical and mycological assessments were conducted weekly until cure.

Main Results:

  • Group 1 (25% OBO emulsion) achieved an 80% cure rate within 1-2 weeks.
  • Group 2 (20% OBO in alcohol) showed a 50% cure rate in 1-2 weeks.
  • Group 3 (pure OBO) demonstrated a high cure rate (93.3%) in 1-3 weeks, with mild irritation as the only side effect.

Conclusions:

  • Oil of bitter orange exhibits fungistatic and fungicidal properties against dermatophytes.
  • OBO is a potentially effective, affordable, and accessible topical antifungal treatment.
  • Further research supports OBO as a promising agent for superficial fungal infections.

Related Concept Videos

Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...